Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds

In this ongoing study, substantially increased ancestral SARS-CoV-2 neutralizing responses were observed 1 month after a third 10-µg BNT162b2 dose given to 5 to 11-year olds versus neutralizing responses post-dose 2. After dose 3, increased neutralizing responses against Omicron BA.1 and BA.4/BA.5 s...

Descripción completa

Detalles Bibliográficos
Autores principales: Simões, Eric A F, Klein, Nicola P, Sabharwal, Charu, Gurtman, Alejandra, Kitchin, Nicholas, Ukkonen, Benita, Korbal, Piotr, Zou, Jing, Xie, Xuping, Sarwar, Uzma N, Xu, Xia, Lockhart, Stephen, Cunliffe, Luke, Lu, Claire, Ma, Hua, Swanson, Kena A, Koury, Kenneth, Shi, Pei-Yong, Cooper, David, Türeci, Ӧzlem, Jansen, Kathrin U, Şahin, Uğur, Gruber, William C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146923/
https://www.ncbi.nlm.nih.gov/pubmed/36929216
http://dx.doi.org/10.1093/jpids/piad015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146923/
https://www.ncbi.nlm.nih.gov/pubmed/36929216
http://dx.doi.org/10.1093/jpids/piad015

Ejemplares similares